Tag results:
colorectal cancer
Intestinal Cell News
Single-Cell and Spatial Analysis Reveal Interaction of FAP+ Fibroblasts and SPP1+ Macrophages in Colorectal Cancer
[Nature Communications] Scientists profiled 54,103 cells from tumor and adjacent tissues to characterize cellular composition and elucidated the potential origin and regulation of tumor-enriched cell types in colorectal cancer.
Immune Regulation News
Targeting T Regulatory Cells: Their Role in Colorectal Carcinoma Progression and Current Clinical Trials
[Pharmacological Research] Regulatory T cells (Tregs) are a form of T cells, which regulate and suppress unwanted activation of the immune system and play a major role in preventing autoimmune diseases.
Intestinal Cell News
ADH1C Inhibits Progression of Colorectal Cancer through the ADH1C/PHGDH /PSAT1/Serine Metabolic Pathway
[Acta Pharmacologica Sinica] Alcohol dehydrogenase 1C (ADH1C) was first identified as a target gene closely associated with the development of CRC by the comprehensive application of transcriptomics, proteomics, metabonomics and in silico analysis.
Intestinal Cell News
Aryl-Hydrocarbon Receptor-Interacting Protein Regulates Tumorigenic and Metastatic Properties of Colorectal Cancer Cells Driving Liver Metastasis
[British Journal of Cancer] The authors revealed new roles for aryl-hydrocarbon receptor-interacting protein in regulating proteins associated with cancer and metastasis to induce tumorigenic and metastatic properties in colon cancer cells driving liver metastasis.
Cancer Stem Cell News
Suppressive Effect of α-Mangostin for Cancer Stem Cells in Colorectal Cancer via the Notch Pathway
[BMC Cancer] Scientists evaluated the selective inhibition of α-mangostin on CSCs in colorectal cancer and the suppressive effect on 5-fluorouracil-induced CSCs.
Intestinal Cell News
MiR-323a Regulates ErbB3/EGFR and Blocks Gefitinib Resistance Acquisition in Colorectal Cancer
[Cell Death & Disease] Scientists detected the receptor tyrosine kinase activity in gefitinib-resistant colorectal cancer cells, pan-erb-b2 receptor tyrosine kinase 3 (ErbB3)/EGFR was significantly activated and provided a potential multi-ErbB treatment target.